Zobrazeno 1 - 10
of 25
pro vyhledávání: '"John E. Mata"'
Autor:
Bernard Séguin, Guangheng Li, Nicolle E. Hofmann, Atiya Mansoor, Shay Bracha, Charles Keller, Elaine T. Huang, Lara E. Davis, Marc M. Loriaux, Jinu Abraham, John E. Mata, Stuart C. Helfand, Kevin Marley, Jeffrey W. Tyner
Publikováno v:
Pediatric Blood & Cancer. 60:1313-1319
Osteosarcomaisthemostcommonmalignantbonetumor,yettheincidenceofosteosarcomaislowenoughtoposeasignificantbarrierto the timely completion of traditionally designed clinical trials.While research laboratories continue to investigate the underlyingmecha
Autor:
Carole Jubert, George S. Bailey, William G. Tracewell, Kenneth W. Turteltaub, Cliff Pereira, Roderick H. Dashwood, John E. Mata, Graham Bench, David E. Williams
Publikováno v:
Cancer Prevention Research. 2:1015-1022
Chlorophyll (Chla) and chlorophyllin (CHL) were shown previously to reduce carcinogen bioavailability, biomarker damage, and tumorigenicity in trout and rats. These findings were partially extended to humans, where CHL reduced excretion of aflatoxin
Autor:
James E. Summerton, Arhie Reid Tyson, Leslie A. Dyal, Scott B. Gustafson, John E. Mata, Margorie E. Slauson, Rosita Rodriguez-Proteau, Christiane V Loehr
Publikováno v:
Nanomedicine: Nanotechnology, Biology and Medicine. 3:297-305
Solid tumors often display metabolic abnormalities that consistently produce low pH in the extracellular space of poorly perfused tissue. These acidic regions may provide a mechanism for drug targeting. Peptides have been designed in such a manner th
Autor:
Michael R. Bishop, Carol R. Angle, Stanley A. Swanson, Stefano R. Tarantolo, John E. Mata, Patrick L. Iversen
Publikováno v:
Journal of Toxicology: Clinical Toxicology. 38:383-387
Phosphorothioate oligonucleotides, in general, possess properties that could be utilized in the development of therapeutic heavy metal chelators.Iron excretion was measured in 16 patients participating in studies to test the safety of OL(1)p53, a 20-
Autor:
Todd J. Page, John E. Mata, Patrick L. Iversen, James R. Neff, Julia A. Bridge, Justin C Siebler
Publikováno v:
Experimental Cell Research. 252:41-49
Telomerase is a ribonucleoprotein that adds 5′-d(TTAGGG)-3′ hexameric repeats onto the 3′ ends of chromosomes. High telomerase activity has been associated with immortal cells, transformed cells, mitogenic stimulation, and proliferative disease
Autor:
Patric L. Iversen, Atsushi Takeda, Shoji Okada, Mai Suzuki, John E. Mata, Harumi Hisada, Manuchair Ebadi
Publikováno v:
ResearcherID
Autor:
John E. Mata, Jennifer M. Simpson, Bernard Séguin, Kevin Marley, William G. Tracewell, Stuart C. Helfand, Shay Bracha, Lisa Brownlee
Publikováno v:
Journal of Experimental & Clinical Cancer Research : CR
Background Osteosarcoma in dogs and humans share many similarities and the dog has been described as an excellent model to study this disease. The median survival in dogs has not improved in the last 25 years. Taurolidine has been shown to be cytotox
Publikováno v:
Journal of Drug Targeting. 2:477-485
5' cholesteryl-conjugated phosphorothioate oligodeoxynucleotides with sequence complementary to the rat CYP2B1 mRNA were evaluated in adult male Sprague-Dawley rats for their pharmacokinetic properties, toxicity, and ability to modulate CYP2B1 expres
Autor:
Lara E, Davis, Nicolle E, Hofmann, Guangheng, Li, Elaine T, Huang, Marc M, Loriaux, Shay, Bracha, Stuart C, Helfand, John E, Mata, Kevin, Marley, Atiya, Mansoor, Jeffrey W, Tyner, Jinu, Abraham, Bernard, Séguin, Charles, Keller
Publikováno v:
Pediatric bloodcancer. 60(8)
Effective targeted therapies are needed in sarcomas, but the biological heterogeneity of these tumors has presented a challenge to clinical integration of small molecule inhibitors in sarcoma treatment. Here we outline a process to personalize therap
Autor:
S.F. Pang, Chiu-Yin Kwan, Alice Y.-C. Liu, Peter D. Kitchener, Edwin E. Daniel, Nien-Tze Chang, Manuchair Ebadi, Patrick L. Iversen, J.-P. Bourreau, Bao-Cun Sun, John E. Mata, Y. Song, Guo-Zhang Jin
Publikováno v:
Neurosignals. 1:I-V